Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. - Wikidata - awgldk - TriplyDB

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.

http://www.wikidata.org/entity/Q46045622

about

Circulating MicroRNAs as Biomarkers for Sepsis Exosomes as miRNA Carriers: Formation-Function-Future Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis Circulating microRNA-223 serum levels do not predict sepsis or survival in patients with critical illness.Circulating miRNAs: Potential Novel Biomarkers for Hepatopathology Progression and Diagnosis of Schistosomiasis Japonica in Two Murine Models.Persistently elevated osteopontin serum levels predict mortality in critically ill patients.Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.Translational biomarkers of acetaminophen-induced acute liver injury Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients.The involvement of regulatory non-coding RNAs in sepsis: a systematic review.Circulating ECV-Associated miRNAs as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis Circulating microRNAs as Potential Biomarkers of Infectious Disease.Non-Coding RNAs in Primary Liver Cancer.The pathogenesis of drug-induced liver injury.Immune regulation in chronic hepatitis C virus infection.Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications.Liver - guardian, modifier and target of sepsis.Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure.Non-coding RNA: a potential biomarker and therapeutic target for sepsis.The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis.Bile: miRNA pattern and protein-based biomarkers may predict acute cellular rejection after liver transplantation.Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis.Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment.Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria.Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases.Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing.Mining of potential microRNAs with clinical correlation - regulation of syndecan-1 expression by miR-122-5p altered mobility of breast cancer cells and possible correlation with liver injury.Increased circulating microRNA-122 is associated with mortality and acute liver injury in the acute respiratory distress syndrome.Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients.as a novel biomarker for alpha-fetoprotein-producing gastric cancer Profiling the circulating miRnome reveals a temporal regulation of the bone injury response

P2860

Q26772133-21F2ADE6-1243-4E97-8B7D-6E5D279D32E8 Q28075728-E53942D5-232D-4ABC-888B-4EAF933397B8 Q30277969-4D0C5A66-3A96-4E30-8957-5AF98B103DCE Q30418874-28EFEE9D-2943-4D97-929D-0DB0516DF66C Q33577437-D07AD6BC-13E8-4359-86C7-BABC9715EF8D Q35055339-C0EC8977-3F70-45FA-8064-5736656D08EC Q35163820-61F055AC-F481-4BF9-9B1F-7F96BF2B2048 Q35729615-27C55520-C3B4-4F86-A242-D5174FBCE4AB Q35814641-B79F4C5D-55FE-4759-BF4F-9E7DCEF92240 Q35840874-73E045BF-173E-4D58-A7E6-62E0767A56E7 Q35843599-9A2A93C6-3296-4F5E-946F-B3FD6CD02022 Q36001451-16205C1A-2F56-4BC6-A6F1-E8C43C13047C Q37314018-DB741A48-E1B6-40F6-8331-C1ABD7C82479 Q37404766-25F652A8-4584-487D-B2D1-EE448A690808 Q37444472-7CC6E544-0F15-41FA-A52D-F0E33268F8D6 Q37632907-E15ECF01-7663-46A7-A920-9D5C51658A79 Q37643903-054B4A01-39FB-466F-8D26-66AA529AED4E Q38541359-8BE64FB4-549E-4906-8877-8614821880F8 Q38849978-ACB34AED-C84C-427E-A612-BE6A0915E2EE Q38902559-9F8040D4-862F-4B33-9DAA-224509D68505 Q38980437-003360F2-2831-4D8F-8444-C3F0B048473E Q39031051-E79A9F67-5910-438F-8786-0F823275B546 Q40722473-E2FD9B5D-4569-4127-885A-2F09A8107B7C Q47103723-66A66BC6-9783-4417-B836-AF9E6E14B7F5 Q47553075-2A2B41B6-CE85-4C82-9667-C9C6C5864AA8 Q51634340-2A156628-10B5-4408-B67B-4B50A9BE7A61 Q51681229-2ACF59C0-31A1-4219-93C2-2D37F9B58881 Q52559151-7BD86383-95BF-4F4A-A859-F30EBCAE4F93 Q52664090-6C815928-D282-4913-8C4F-BA458377C4E0 Q52722360-64118495-F13C-4F51-8B67-58980F099130 Q54204360-F02D9AC3-3A03-4B90-B436-1D5C3964134B Q55253535-BC4ABD21-F9F6-44EB-ADB2-AEE92E895A9B Q55339600-DEF72F95-BC11-4088-A51E-AB8ECCC34955 Q55347744-54F853FE-1EB7-4E9D-BB2A-3E8B912D7605 Q55500120-88B33329-3E68-492E-A674-31ED9CA6BB2C Q55513504-98C1F5D0-5CDE-4909-833F-E6FD28EB06BF Q58566662-5C2AB122-C16B-4E37-9D1D-2FDC90FFE074 Q59123165-256FD7E7-1877-43BE-873B-4F4CBEE376A7

P2860

Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases.

http://www.wikidata.org/entity/Q46045622

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@en

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@nl

type

label

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@en

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@nl

prefLabel

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@en

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@nl

P1433

Q46045622-9603126E-DCEF-4F66-A957-67FB5557D0D5

P1476

Q46045622-0B9EBA52-8514-42DA-8F4D-88F02160C3F3

P2093

Q46045622-036E1408-33C0-431D-9272-8732EA158A52

Q46045622-0391BE0B-29B2-48AD-BF80-FBEE00A78701

Q46045622-21DD9107-5734-4B7D-8EA5-02FFB29111F9

Q46045622-26F50BFB-AFD0-47CC-8337-1BBEF0D80013

Q46045622-4D383303-8D5F-4B35-8D6D-16A5F548867C

Q46045622-5AC82D71-E625-4F98-9589-7BE7D4B34615

Q46045622-7C7879CE-2069-4FFC-9B1A-1EFC95E63D53

Q46045622-A0F96A25-9D08-410B-935B-AC7B139C249E

Q46045622-A64D5DD0-355D-4A63-964D-2D756F4A7507

Q46045622-AB181A46-769E-4920-9CD5-D04A2586E9F1

P2860

Q46045622-0404BB86-BB1A-405E-B510-FFF8C2D4F939

Q46045622-0F3A756D-0FE0-40BC-B8E6-E672CA87A107

Q46045622-0FFB7E3B-6AD8-444A-8A52-9B884A50972B

Q46045622-19C9B87B-BC3E-4F07-A35C-6D7E4435FD11

Q46045622-1EC176E8-7E86-4883-89CA-9CC40A59DA49

Q46045622-29062C42-747B-4F56-9173-324F918C1712

Q46045622-2EB5B445-DC3C-40FC-868E-C2E3622E61C5

Q46045622-330B3C2A-BC79-4E17-9133-ADD751AAEC7D

Q46045622-411F940E-196B-4B92-A70D-3BFF46C1AA18

Q46045622-418142CC-A8BB-44CB-B5DD-D989FE066D0B

P304

Q46045622-88599DE9-9720-4A4C-9833-7BA1A08344F9

P31

Q46045622-00FFCFE4-8A1E-4078-B517-A0C5C6A19F87

P356

Q46045622-2F4574C7-268B-4F5B-B923-4F8DE50B0B7C

P433

Q46045622-A811C0CA-E7ED-4836-A767-58D80559ABE3

P478

Q46045622-9C47B122-0FB6-4E41-9FD0-6DF073581CF8

P577

Q46045622-271A46E4-699E-4A93-B190-4EBC83B27FE3

P698

Q46045622-9E768C10-B66A-4317-B71B-669806041A64

P921

Q46045622-C421A805-E8B8-4042-AB8C-67A00B3EF2B7

P356

P1433

Liver International

P1476

Elevated miR-122 serum levels ...... jury in inflammatory diseases.

@en

P2093

Alexander Koch

http://www.w3.org/2001/XMLSchema#string

Anne T Schneider

http://www.w3.org/2001/XMLSchema#string

Christian Trautwein

http://www.w3.org/2001/XMLSchema#string

Christiane Koppe

http://www.w3.org/2001/XMLSchema#string

Christoph Roderburg

http://www.w3.org/2001/XMLSchema#string

David Vargas Cardenas

http://www.w3.org/2001/XMLSchema#string

Fabian Benz

http://www.w3.org/2001/XMLSchema#string

Frank Tacke

http://www.w3.org/2001/XMLSchema#string

Henning W Zimmermann

http://www.w3.org/2001/XMLSchema#string

Jeremie Gautheron

http://www.w3.org/2001/XMLSchema#string

P2860

Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

miR-221 overexpression contributes to liver tumorigenesis

Circulating microRNAs, potential biomarkers for drug-induced liver injury

The functions of animal microRNAs

Identification of tissue-specific microRNAs from mouse

The diverse functions of microRNAs in animal development and disease

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

Phylogenetic shadowing and computational identification of human microRNA genes

Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers

P304

1172-1184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12627

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25039534

http://www.w3.org/2001/XMLSchema#string

P921